Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-07-01 | New | $61,841,225 | $61,841,225 | Equity Only | 06b | SEC link |
| 2024-04-12 | New | $10,000,000 | $10,000,000 | Debt Only | 06b | SEC link |
| 2021-01-13 | New | $1,075,255 | $1,075,255 | Equity Only | 06b | SEC link |
| 2020-06-26 | Amended | $337,500 | $67,500 | Debt Only | 06b | SEC link |
| 2019-11-15 | New | $270,000 | $270,000 | Debt Only | 06b | SEC link |
| Name | Role |
|---|---|
| Robert Jacks | Director, Executive |
| David Katz | Executive |
| Nanna L?Neborg | Director |
| Niall O'donnell | Director |
| Jonathan Root | Director |
| Zach Scheiner | Director |
| Peter Thompson | Director |
| Klaus Veitinger | Director |